Coiled Therapeutics (LSE:COIL) Inventories, Raw Materials & Components: £0.00 Mil (As of Dec. 2025)


What is Coiled Therapeutics Inventories, Raw Materials & Components?

Coiled Therapeutics LSE:COIL Inventories, Raw Materials & Components is £0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Coiled Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2025 was £0.00 Mil.

Coiled Therapeutics Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Coiled Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coiled Therapeutics Inventories, Raw Materials & Components Chart

Coiled Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.00 0.00

Coiled Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Coiled Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of £0.00 Mil mean?
Coiled Therapeutics (LSE:COIL) has a Inventories, Raw Materials & Components of £0.00 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Coiled Therapeutics and its competitors.
Is Coiled Therapeutics' Inventories, Raw Materials & Components too high?
Coiled Therapeutics' current Inventories, Raw Materials & Components is £0.00 Mil.
How does Coiled Therapeutics' Inventories, Raw Materials & Components compare to VRTX and REGN?
Coiled Therapeutics' Inventories, Raw Materials & Components of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Coiled Therapeutics and its competitors. Coiled Therapeutics's current Inventories, Raw Materials & Components is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coiled Therapeutics stock overvalued right now?
Coiled Therapeutics (LSE:COIL) has a current Inventories, Raw Materials & Components of £0.00 Mil. The current Inventories, Raw Materials & Components is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Coiled Therapeutics (LSE:COIL), the current Inventories, Raw Materials & Components is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coiled Therapeutics Business Description

Other Exchanges COTXF:USA0AG0:Germany
Address 85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Coiled Therapeutics PLC principal activity of the Company is to develop pre-clinical next generation medicines focused on hard-to-treat cancers. The Group operated in the single business segment of biotechnology.